ArticleThe American journal of case reports2025
Use of Bonebridge Implant in a Child with Congenital Cholesteatoma: A Case Report.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Congenital cholesteatoma is a relatively rare condition accounting for about 2% to 5% of all cholesteatomas. Congenital cholesteatomas pose a significant challenge to treat. Failure to detect cholesteatoma early can lead to progressive and severe damage to middle ear structures, resulting in hearing loss. If conventional hearing aids are not a viable option, a bone conduction implant may be considered. One of the most successful is the Bonebridge implant, designed for adults and children with conductive or mixed hearing loss. The aim of this study was to analyze the surgical implications, efficacy, and safety of the Bonebridge implant in our patient. CASE REPORT We report the case of a 10-year-old girl with a diagnosis of congenital cholesteatoma and progressive hearing loss. She had undergone multiple surgical procedures, with no lasting results. To improve hearing, she underwent a comprehensive diagnostic evaluation for an implantable bone conduction device, and she was found to be eligible for a Bonebridge implant. To verify the improvement in hearing, pure-tone audiometry, speech audiometry, and the Polish Matrix Sentence Test were performed before implantation, during processor activation, and at the follow-up visit 3 months later. Follow-up was planned at 3 and 6 months to monitor for recurrence of cholesteatoma, with cavity checks every 4 weeks. CONCLUSIONS After Bonebridge implantation, the patient demonstrated significant improvement in hearing thresholds and speech recognition. Implantation was uncomplicated and regular follow-ups were scheduled to monitor for recurrent cholesteatoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.